CSL Finance Q2 FY26 PAT up 37% to Rs 24.5 cr; new ESOP plan approved

Profit growth above 25%Results View source PDF Explain this filing

CSLFINANCE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+11.6%Reaction day

₹273.00

prior close

₹279.00

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.1%+11.7% vs market

Non Banking Financial Company (NBFC) peers, median of 203sector+0.0%+11.6% vs sector

On the reaction day the stock moved 11.7 pts more than Nifty Microcap 250 and 11.6 pts more than its Non Banking Financial Company (NBFC) peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.2

10m

+1.4

15m

+1.5

30m

+0.9

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+11.6-0.1+11.7+0.0+11.6

Next day

+12.1+0.5+11.6-0.3+12.4

+13.6-0.3+13.9-0.8+14.3

+10.4-0.5+10.9-1.4+11.8

+7.8-0.8+8.6-2.1+9.9

+4.8-2.3+7.1-2.4+7.2

+2.2-2.8+5.0-3.6+5.8

15d

+8.1-4.9+12.9-4.0+12.0

+8.2-4.7+12.9-4.8+13.0

+7.0-7.7+14.7-7.6+14.6

-9.0-7.8-1.2-10.7+1.7

UpDownMarket · Nifty Microcap 250Sector · Non Banking Financial Company (NBFC) peers, median of 203Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

CSL Finance posted Q2 FY26 revenue from operations of Rs 63.7 cr, up about 18 percent YoY. Profit after tax jumped 37 percent to Rs 24.5 cr from Rs 17.9 cr a year ago. H1 FY26 PAT rose 26 percent to Rs 45.8 cr against Rs 36.3 cr. Loan book stood at around Rs 1,272 cr versus Rs 1,025 cr last year. Board also approved new ESOP 2025 via trust route and decided to wind up the older 2016 scheme, with existing grants continuing.

Likely market impact

Strong quarterly earnings growth signals healthy loan book expansion and profitability; new ESOP may lead to some dilution for existing shareholders over time.